Advertisement

Topics

Amicus’ rare disease drug, once indefinitely delayed, wins FDA approval

16:07 EDT 10 Aug 2018 | STAT

After 12 years, Amicus Therapeutics has won Food and Drug Administration approval for its first therapy, a treatment for a rare and sometimes deadly disease.

Original Article: Amicus’ rare disease drug, once indefinitely delayed, wins FDA approval

NEXT ARTICLE

More From BioPortfolio on "Amicus’ rare disease drug, once indefinitely delayed, wins FDA approval"

Advertisement
Quick Search
Advertisement
Advertisement